Roland_Stocker

Roland Stocker

Roland Stocker

Swiss Australian biochemist (born 1956)

Roland Stocker (born 5 October 1956 in Switzerland) is a Swiss Australian biochemist who discovered the antioxidant activity of bilirubin.[1] He is a former Olympic rower and has represented Switzerland at the 1980 Summer Olympics.[2]

Early life and education

Stocker was awarded a Diplom [im] Naturwissenschaften und Mathematik (Dipl. Natw.), or Diploma in/of Natural Science, from the ETH Zurich in 1981 and a Ph.D. from the Australian National University in 1985.[3]

Career

Stocker has made significant contributions to the understanding of the molecular action of Alpha-Tocopherol (vitamin E) during the oxidation of lipoproteins,[4][5] the antioxidant activities of ubiquinol-10 in lipoproteins,[6] the contribution of oxidation of low-density lipoprotein to atherosclerosis,[7] the understanding of how antioxidants and heme oxygenase-1 protect against atherosclerosis,[8][9] the role of myeloperoxidase to atherosclerotic plaque destabilization,[10] and the contribution of tryptophan metabolism by indoleamine 2,3-dioxygenase in the regulation of vascular tone in inflammation.[11][12]

Stocker is recognized as a "redox pioneer".[13] He is a Fellow of the Swiss Academy of Medical Sciences and the Australian Academy of Health and Medical Sciences.

Formerly, Stocker held an appointment as a professor at the University of New South Wales and the University of Sydney, Australia. Currently, he is Group Leader at the Heart Research Institute.[14]

Personal life

Stocker lives in Sydney, Australia with his wife, Maree Stenglin.

Stocker's twin brother, Peter, was also an Olympic rower for Switzerland.

References

  1. [1]
    Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987). "Bilirubin is an antioxidant of possible physiological importance". Science. 235 (4792): 1043–6. Bibcode:1987Sci...235.1043S. doi:10.1126/science.3029864. PMID 3029864.
  2. [2]
    "Roland Stocker Bio, Stats, and Results | Olympics at Sports-Reference.com". 18 April 2020. Archived from the original on 18 April 2020.
  3. [3]
    "Research Supervisor Connect". The University of Sydney.
  4. [4]
    Bowry VW, Ingold KU, Stocker R (1992). "Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant". Biochem J. 288 (2): 341–4. doi:10.1042/bj2880341. PMC 1132016. PMID 1463440.
  5. [5]
    Ingold KU, Bowry VW, Stocker R, Walling C (1993). "Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein". Proc Natl Acad Sci U S A. 90 (1): 45–9. Bibcode:1993PNAS...90...45I. doi:10.1073/pnas.90.1.45. PMC 45596. PMID 8419943.
  6. [6]
    Stocker R, Bowry VW, Frei B (1991). "Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol". PNAS. 88 (5): 1646–50. Bibcode:1991PNAS...88.1646S. doi:10.1073/pnas.88.5.1646. PMC 51081. PMID 2000375.
  7. [7]
    Stocker R, Keaney JF Jr (2004). "Role of oxidative modifications in atherosclerosis". Physiol Rev. 84 (4): 1381–478. doi:10.1152/physrev.00047.2003. PMID 15383655.
  8. [8]
    Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, Croft KD, Mori TA, Tanous D, Adams MR, Lau AK, Stocker R (2006). "Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging". J Exp Med. 203 (4): 1117–27. doi:10.1084/jem.20052321. PMC 2118288. PMID 16606673.
  9. [9]
    Stocker R, Perrella MA (2006). "Heme oxygenase-1: a novel drug target for atherosclerotic diseases?". Circulation. 114 (20): 2178–89. doi:10.1161/CIRCULATIONAHA.105.598698. PMID 17101869.
  10. [10]
    Rashid I, Maghzal GJ, Chen Y, Cheng D, Talib J, Newington D, Ren M, Vajandar SK, Searle A, Maluenda A, Lindstedt E, Jabbour A, Kettle AJ, Bongers A, Power C, Michaëlsson E, Peter K, Stocker R (2018). "Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque". Eur Heart J. 39 (35): 3301–10. doi:10.1093/eurheartj/ehy419. PMID 30219874. S2CID 52281012.
  11. [11]
    Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M, Changsirivathanathamrong D, Wu BJ, Ball HJ, Thomas SR, Kapoor V, Celermajer DS, Mellor AL, Keaney JF Jr, Hunt NH, Stocker R (2010). "Kynurenine is an endothelium-derived relaxing factor produced during inflammation". Nat Med. 16 (3): 279–85. doi:10.1038/nm.2092. PMC 3556275. PMID 20190767.
  12. [12]
    Stanley CP, Maghzal GJ, Ayer A, Talib J, Giltrap AM, Shengule S, Wolhuter K, Wang Y, Chadha P, Suarna C, Prysyazhna O, Scotcher J, Dunn LL, Prado FM, Nguyen N, Odiba JO, Baell JB, Stasch JP, Yamamoto Y, Di Mascio P, Eaton P, Payne RJ, Stocker R (2019). "Singlet molecular oxygen regulates vascular tone and blood pressure in inflammation". Nature. 566 (7745): 548–552. Bibcode:2019Natur.566..548S. doi:10.1038/s41586-019-0947-3. hdl:1959.17/169229. PMID 30760924. S2CID 61156683.
  13. [13]
    Hunt NH (2011). "Redox pioneer: professor Roland Stocker". Antioxid Redox Signal. 15 (12): 3101–5. doi:10.1089/ars.2010.3842. PMID 21609251.
  14. [14]
    "Arterial Inflammation and Redox Biology • Heart Research Institute". Heart Research Institute.
Share this article:

This article uses material from the Wikipedia article Roland_Stocker, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.